Autistic Disorder

Psychiatry·MeSH: Autistic Disorder

12 drugs in development·12 companies·1 clinical trial

Drug Pipeline by Phase

Approved(12)

Drug	Company
aripiprazole	Mylan II B.V. (MYL)
risperidone	LANNETT CO INC (LCI)
risperidone	PRECISION BIOSCIENCES INC (DTIL)
risperidone	Amneal Pharmaceuticals, Inc. (AMRX)
risperidone	REATA PHARMACEUTICALS INC (RETA)
risperidone	AlphaTON Capital Corp (ATON)
risperidone	Prestige Consumer Healthcare Inc. (PBH)
risperidone	Aptinyx Inc. (APTX)
risperidone	ANI PHARMACEUTICALS INC (ANIP)
risperidone	SUNSET ISLAND GROUP (SUN)
risperidone	DR REDDYS LABORATORIES LTD (RDY)
risperidone	Synthorx, Inc. (THOR)

BioSniper tracks 12 drugs in development for Autistic Disorder across 12 companies.

There are 1 clinical trial targeting Autistic Disorder tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.